Company profile

Scopio Labs , Ltd.

Scopio Labs , Ltd. has 3 AI-enabled medical devices on the FDA list. The first decision was on October 2, 2020 and the most recent on June 27, 2025 (X100/X100HT with Full Field Peripheral Blood Smear (PBS) Application). Its most common review panel is Hematology (3 devices).

3AI devices
2020First decision
2025Latest decision
1Specialties

Per year

2020: 12022: 12025: 1
202020222025
Scopio Labs , Ltd. AI devices per year: 2020 1, 2022 1, 2025 1

By specialty

  • Hematology3

Timeline

  1. X100/X100HT with Full Field Peripheral Blood Smear (PBS) Application · Hematology · JOY
  2. X100HT with Slide Loader with Full Field Peripheral Blood Smear (PBS) Application · Hematology · JOY
  3. X100 with Full Field Peripheral Blood Smear (PBS) Application · Hematology · JOY